• OPEN AN ACCOUNT
Indian Indices
Sensex
76,758.84 699.07
( 0.92%)
Global Indices
Nasdaq
51,969.87 237.22
(0.46%)
Dow Jones
7,434.30 5.00
(0.07%)
Hang Seng
64,397.99 -2,024.61
(-3.05%)
Nikkei 225
10,738.51 99.34
(0.93%)
Forex
USD-INR
96.67 0.19
(0.20%)
EUR-INR
110.18 0.12
(0.10%)
GBP-INR
129.04 -0.01
(0.00%)
JPY-INR
0.59 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Mankind Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543904
INE634S01028
397.024678
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MANKIND
48.69
103472.01
EPS(TTM)
Face Value()
Div & Yield %
51.46
1
0.04
 

lloyds engineering works ltd
Nimbus Projects reports standalone net profit of Rs 25.48 crore in the March 2026 quarter
May 28,2026
Net profit of Nimbus Projects reported to Rs 25.48 crore in the quarter ended March 2026 as against net loss of Rs 17.22 crore during the previous quarter ended March 2025. Sales rose 1800.00% to Rs 0.38 crore in the quarter ended March 2026 as against Rs 0.02 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 12.13 crore in the year ended March 2026 as against net loss of Rs 12.75 crore during the previous year ended March 2025. Sales declined 2.65% to Rs 1.47 crore in the year ended March 2026 as against Rs 1.51 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.380.02 1800 1.471.51 -3
OPM %-2715.79-82550.00 --3408.84-2886.09 -
PBDT26.17-18.42 LP -10.88-10.01 -9
PBT26.08-18.46 LP -11.11-10.19 -9
NP25.48-17.22 LP -12.13-12.75 5